Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
2 major insurers draw lines in the sand for pricey PCSK9 coverage
BioPharma Dive
Wed, 09/2/15 - 12:34 pm
PCSK9 inhibitors
insurers
Regeneron
Sanofi
Amgen
Praluent
Repatha
Approval Of Repatha May Give Amgen A $5B Boost
Seeking Alpha
Mon, 08/31/15 - 05:28 pm
Repatha
Amgen
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Amgen, Inc. Or Regeneron Pharmaceuticals Inc - Who Would Win The PCSK-9 Race?
Bidness, ETC
Mon, 08/31/15 - 11:13 am
PCSK9 inhibitors
Amgen
Regeneron
Repatha
Praluent
The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles
Forbes
Fri, 08/28/15 - 08:19 am
drug pricing
Repatha
Praluent
Sanofi
Regeneron
Amgen
PCSK9 inhibitors
How Big Biotech Spents It’s Money
Barron's
Fri, 08/21/15 - 05:23 pm
biotech
Amgen
Biogen
Regeneron
Celgene
Gilead
Alexion
Payers Set To Play Hardball On PCSK9 Pricing
Investors.com
Fri, 08/14/15 - 11:22 am
payer negotiation
drug pricing
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
hepatitis C
Express Scripts
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
BioPharma Dive
Mon, 08/10/15 - 10:53 am
CVS
PCSK9 inhibitors
formulary
Sanofi
Regeneron
Praluent
Amgen
Repatha
Will Regeneron's New Drug Break The Bank?
Motley Fool
Wed, 08/5/15 - 09:28 am
Regeneron
Praluent
drug pricing
Sanofi
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Eylea
Lucentis
Avastin
Regeneron
Roche/Genentech
Regeneron Tops Q2 Estimates, Shares Surge
Benzinga
Tue, 08/4/15 - 08:23 am
Regeneron
earnings
Sanofi draws a $14,600 line in the sand for Praluent payer fight
Fierce Pharma Marketing
Tue, 07/28/15 - 10:22 am
Sanofi
Praluent
Repatha
Amgen
Regeneron
drug pricing
PCSK9 inhibitors
Sanofi links with Regeneron in $2.2 bln cancer drug push
Yahoo/Reuters
Tue, 07/28/15 - 10:03 am
Sanofi
Regeneron
cancer immunotherapy
R&D
Why Regeneron’s Approval is Bad News For Esperion Therapeutics
Barron's
Mon, 07/27/15 - 01:55 pm
Regeneron
Esperion Therapeutics
Sanofi
Praluent
Amgen
Repatha
ETC-1002
Docs are Excited About Prescribing Those New Cholesterol Drugs: Survey
WSJ Pharmalot
Fri, 07/24/15 - 03:47 pm
physicians
PCSK9 inhibitors
Praluent
Repatha
Amgen
Sanofi
Regeneron
Sanofi's big new cholesterol drug wins European green light
Yahoo/Reuters
Fri, 07/24/15 - 10:05 am
Praluent
Sanofi
Regeneron
Europe
PCSK9 inhibitors
Amgen
Repatha
Praluent's FDA review looms, but questions persist
Medical Marketing and Media
Wed, 07/22/15 - 09:45 pm
Praluent
FDA
PCSK9 inhibitors
Sanofi
Regeneron
2015’s Top 6 Big Pharma Headlines Thus Far
Motley Fool
Wed, 07/22/15 - 08:36 am
Pfizer
M&A
Hospira
AbbVie
Pharmacyclics
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Express Scripts
Bristol-Myers Squibb
Opdivo
Why July Will Be an Exciting Month for Regeneron Pharmaceuticals
Motley Fool
Sun, 07/12/15 - 09:41 am
Regeneron
FDA
Sanofi
Praluent
Sanofi, Regeneron say Japan study shows Praluent drug lowers cholesterol
Yahoo/Reuters
Thu, 07/9/15 - 10:14 am
Sanofi
Regeneron
Japan
Praluent
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »